Health & Nutrition

bg
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough

Drugmakers bet billions that targeted radiation could become...

Bristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested...

bg
Is Creatine Safe and Efficient for High Homocysteine? 

Is Creatine Safe and Efficient for High Homocysteine? 

Those on a healthy plant-based diet who have elevated homocysteine levels despite...

bg
Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results

Pfizer says its experimental drug for deadly condition...

The results could pave the way for Pfizer's drug ponsegromab to become the first-ever...

bg
Eli Lilly says it will invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs

Eli Lilly says it will invest $1.8 billion to expand manufacturing...

Demand for Eli Lilly's Zepbound and Mounjaro has outstripped supply over the last...

bg
Gilead says its twice-yearly shot cut HIV infections by 96% in trial

Gilead says its twice-yearly shot cut HIV infections by...

The data sets the stage for likely approval of Gilead's lenacapavir for HIV prevention.

bg
Digital health company Noom to offer compounded GLP-1 drug through new weight loss program

Digital health company Noom to offer compounded GLP-1 drug...

Digital health company Noom is offering compounded GLP-1 drugs to patients in new...

bg
Apple turning AirPods into hearing aids underscores effort to crack massive health market

Apple turning AirPods into hearing aids underscores effort...

Apple is using its newest AirPods Pro as a way to help break into the health industry,...

bg
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs

Eli Lilly to invest $1.8 billion to expand manufacturing...

Demand for Eli Lilly's Zepbound and Mounjaro has outstripped supply over the last...

bg
Moderna shares plunge on plans to cut $1.1 billion in costs, launch 10 new products by 2027

Moderna shares plunge on plans to cut $1.1 billion in costs,...

Moderna is deprioritizing certain parts of its pipeline, which involves pausing...

bg
Gilead's twice-yearly shot cut HIV infections by 96% in trial

Gilead's twice-yearly shot cut HIV infections by 96% in...

The data sets the stage for likely approval of Gilead's Lenacapavir for HIV prevention.